Canada markets close in 3 hours 17 minutes

Revelation Biosciences, Inc. (REVB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0450+0.0550 (+2.76%)
As of 12:31PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.25M
Enterprise Value 9.47M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.34
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.02

Trading Information

Stock Price History

Beta (5Y Monthly) 0.17
52-Week Change 3-94.18%
S&P500 52-Week Change 328.04%
52 Week High 336.9000
52 Week Low 31.7800
50-Day Moving Average 32.3125
200-Day Moving Average 312.5245

Share Statistics

Avg Vol (3 month) 3126.29k
Avg Vol (10 day) 338.59k
Shares Outstanding 51.63M
Implied Shares Outstanding 61.63M
Float 81.63M
% Held by Insiders 10.32%
% Held by Institutions 11.98%
Shares Short (Apr 30, 2024) 417.74k
Short Ratio (Apr 30, 2024) 40.39
Short % of Float (Apr 30, 2024) 41.09%
Short % of Shares Outstanding (Apr 30, 2024) 41.09%
Shares Short (prior month Mar 28, 2024) 432.81k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Jan 25, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-61.08%
Return on Equity (ttm)-3.12%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.63M
Net Income Avi to Common (ttm)-120.25k
Diluted EPS (ttm)-0.5300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.99M
Total Cash Per Share (mrq)7.34
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.18
Book Value Per Share (mrq)25.13

Cash Flow Statement

Operating Cash Flow (ttm)-7.29M
Levered Free Cash Flow (ttm)-4.11M